RegisterLogin

BND-35

CAT: 0804-HY-P991307Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P991307Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BND-35 is a human monoclonal antibody (mAb) targeting LILRB4/ILT3/CD85k. BND-35 blocks the interaction of ILT3 with APOE and fibronectin, enhances the pro-inflammatory activity of various myeloid cells, and reverses ILT3-mediated immunosuppression of T cells by various suppressive myeloid cells. BND-35 has anti-tumor activity in the hILT3 transgenic mouse tumor model[1].
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Peretz T, et al. BND-35, a novel anti-ILT3 antibody for remodulation of the tumor microenvironment[J]. Cancer Research, 2024, 84 (6_Supplement) : 3920-3920.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-101946-01AS-35
HY-149232HPK1-IN-35
HY-175253YZ-35
HY-178762SRIPK1-IN-35
HY-178908FLT3-IN-35
HY-149392HBV-IN-35
HY-149709ICMT-IN-35
HY-163369HDAC6-IN-35
HY-155714AChE-IN-35
HY-147900PI3K-IN-35

Alternative Products

CatalogName
T9901A-1047-01BND-35
HV126026-01Research Grade Anti-Human CD85k/LILRB4/ILT3 (BND-35)
A136511Anti-CD85k/LILRB4/ILT3 (BND-35) Biosimilar (Monoclonal, IgG)
ST867-500mlBeyoCleanTM BND-10 Preservative
ABT-810-105-Bromo-5-nitro-1,3-dioxane (BND)
DHJ26401Research Grade Anti-Human CD85j/LILRB1/ILT2 (BND-22)
E21-M89Interleukin-35/IL-35
MBS343184-01Interleukin-35 (IL-35)
T14326-01AS-35
A136262Anti-CD85j/LILRB1/ILT2 (BND-22) Biosimilar (Monoclonal, IgG2a, kappa)

Popular Products